| 000 | 01877 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514080147.0 | ||
| 264 | 0 | _c20040112 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M307187200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlphey, Magnus S | |
| 245 | 0 | 0 |
_aThe crystal structure of Leishmania major 3-mercaptopyruvate sulfurtransferase. A three-domain architecture with a serine protease-like triad at the active site. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cNov 2003 |
||
| 300 |
_a48219-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCatalysis |
| 650 | 0 | 4 | _aCatalytic Domain |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aCysteine _xchemistry |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aLeishmania major _xenzymology |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 | _aProtein Folding |
| 650 | 0 | 4 | _aProtein Structure, Secondary |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xchemistry |
| 650 | 0 | 4 |
_aSulfurtransferases _xchemistry |
| 650 | 0 | 4 |
_aTacrolimus _xchemistry |
| 650 | 0 | 4 |
_aThiosulfate Sulfurtransferase _xchemistry |
| 700 | 1 | _aWilliams, Roderick A M | |
| 700 | 1 | _aMottram, Jeremy C | |
| 700 | 1 | _aCoombs, Graham H | |
| 700 | 1 | _aHunter, William N | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 278 _gno. 48 _gp. 48219-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M307187200 _zAvailable from publisher's website |
| 999 |
_c12722386 _d12722386 |
||